In the European medical devices industry, there were 46 M&A deals announced in Q2 2023, worth a total value of $201.9m, according to GlobalData’s Deals Database. The $69.8m minority acquisition of biocorp production by novo nordisk was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, M&A activity in Europe decreased by 58% in Q2 2023 compared with the previous quarter’s total of $484.5m and fell by 91% as compared to Q2 2022. Related deal volume remained flat in Q2 2023 versus the previous quarter and was 19% lower than in Q2 2022.
The top-ranked financial advisors supporting these M&A deals in Europe in Q2 2023 were Altor Equity Partners; IMAP; Investec with 2, 2, 2 deals respectively.
The top-ranked legal advisors supporting these M&A deals in Europe Q2 2023 were CMS Legal Services EEIG; Advokatfirman Vinge KB; AKD with 5, 2, 2 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.